Journal of Neuro-Oncology
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases
Authors: Wernicke AG, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Clifford Chao KS, Christos P, Kovanlikaya I, Pannullo S, Boockvar JA, Stieg PE, Schwartz TH.
Published: 01/08/2014
<a href="https://isoray.com/research-category/brachytherapy/">Brachytherapy</a>, <a href="https://isoray.com/research-category/brachytherapy/brain/">Brain</a>, <a href="https://isoray.com/research-category/results/quality-of-life/">Quality of Life</a>

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center